Pyrocoll, an antibiotic, antiparasitic and antitumor compound produced by a novel alkaliphilic Streptomyces strain

Journal of Antibiotics

Volumn 56, Issue 7, 2003, Pages 639-646

  Dieter, Anke ^a   Hamm, Andreas ^b   Fiedler, Hans Peter ^a   Goodfellow, Michael ^c   Müller, Werner E G ^d   Brun, Reto ^e   Beil, Winfried ^f   Bringmann, Gerhard ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; CIGARETTE SMOKE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHROBACTER; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIODE; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PROTOZOON; PYROCOLL; SCREENING; STREPTOMYCES; STRUCTURE ANALYSIS; TAXONOMY; TRYPANOSOMA CRUZI; TRYPANOSOMA RHODESIENSE; TUMOR CELL LINE;

ARTHROBACTER; STREPTOMYCES;

EID: 0042031103     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.56.639     Document Type: Article

References (29)

1. Bertasso, M.; M. Holzenkämpfer, A. Zeeck, E. Stackebrandt, W. Beil & H.-P. Fiedler: Ripromycin and other polycyclic macrolactams from Streptomyces sp. Tü 6239: taxonomy, fermentation, isolation and biological properties. J. Antibiotics 56: 364-371, 2003
2. Fiedler, H.-P.: Biosynthetic capacities of actinomycetes. 1. Sceening for secondary metabolites by HPLC and UV-visible absorbance spectral libraries. Nat. Prod. Lett. 2: 119-128, 1993
3. 13C-NMR-Spektren und Biogenese von Resistomycin und Resistoflavin aus Streptomyces griseoflavus B 71 (Actinomycetales). Liebigs Ann. Chem.: 835-843, 1983
4. Küster, E.: Outline of a comparative study of criteria used in characterization of the actinomycetes. Int. Bull. Bacteriol. Nomencl. Taxon 9: 97-104, 1959
5. Kelly, K. L.: Centroid notations for the revised ISCC-NBS color-name blocks. J. Res. Nat. Bureau Standards USA 61: 427, 1958
6. National Bureau of Standards: ISCC-NBS Color-Name Charts Illustrated with Centroid Colors (Supplement to National Bureau of Standards USA Circular 553), National Bureau of Standards, USA, 1964
7. O'Donnell, A. G.; C. Falconer, M. Goodfellow, A. C. Ward & E. Williams: Biosystematics and diversity amongst novel carboxydotrophic actinomycetes. Antonie van Leeuwenhoek 64: 325-340, 1993
8. Staneck, J. L. & G. D. Roberts: Simplified approach to the identification of aerobic actinomycetes by thin-layer chromatography. Appl. Microbiol. 28: 226-231, 1974
9. Kim, S. B.; C. Falconer, E. Williams & M. Goodfellow: Streptomyces thermocarboxydovorans sp. nov. and Streptomyces thermocarboxydus sp. nov., two moderately thermophilic carboxydotrophic species from soil. Int. J. Syst. Bacteriol. 48: 59-68, 1998
10. GuangHua Qiao, G.; W. Meutermans, M. Wah Wong, M. Träubel & C. Wentrup: (Cyanovinyl)ketenes from azafulvenones. An apparent retro-Wolff rearrangement. J. Am. Chem. Soc. 118: 3852-3861, 1996
11. Grever, M. R.; S. A. Shepartz & B. A. Chabner: The National Cancer Institute: cancer drug discovery and development program. Semin. Oncol. 19: 622-638, 1992
12. Müller, W. E. G.; A. Maidhof, R. K. Zahn, H. C. Schröder, M. J. Gasic, D. Heidemann, A. Bernd, B. Kurelec, E. Eich & G. Seibert: Potent antileukemic activity of the novel cytostatic agent avarone and its analogues in vitro and in vivo. Cancer Res. 45: 4822-4827, 1985
13. Schröder, H. C.; M. Bégin, R. Klöcking, E. Matthes, A. S. Sarma, M. Gasic & W. E. G. Müller: Avarol restores the altered prostaglandin and leukotriene metabolism in monocytes infected with human immunodeficiency virus type 1. Virus Res. 21: 213-223, 1991
14. Sachs, L.: Angewandte Statistik. Springer, Berlin, 1984
15. Desjardins, R. E.; C. J. Canfield, D. Haynes & J. Chulay: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16: 710-718, 1979
16. Ridley, R. G.; W. Hofheinz, H. Matile, C. Jacquet, A. Dorn, R. Masciadri, S. Jolidon, W. F. Richter, A. Guenzi, M. A. Girometta, H. Urwyler, W. Huber, S. Thaitong & W. Peters: 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 40: 1846-1854, 1996
17. Baltz, T.; D. Baltz, C. Giroud & J. Crockett: Cultivation in a semi-defined medium of animal infective forms of Trypanosoma bruccei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J. 4: 1273-1277, 1985
18. Räz, B.; M. Iten, Y. Grether-Bühler, R. Kaminsky & R. Brun: The Alamar blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro. Acta Trop. 68: 139-147, 1997
19. NIST-Mass Spectral Search Database V 1.6, National Institute of Standards and Technologic, US
20. Schumacher, J. N.; C. R. Green, F. W. Best & M. P. Newell: Smoke composition. An extensive investigation of the water-soluble portion of cigarette smoke. J. Agric. Food Chem. 25: 310-320, 1977
21. Boatman, R. J. & H. W. Whitlock: Some novel reactions of pyrrolcarboxylic acid chlorides. J. Org. Chem. 41: 3050-3051, 1976
22. Pschyrembel, W.; C. Zink & O. Dornblüth: Pschyrembel Klinisches Wörterbuch, 255th Ed., p. 1014. De Gruyter, Berlin, 1986
23. AL. In Bergey's Manual of Systematic Bacteriology, Vol. 4. Ed. S. T. Williams et al., pp. 2452-2492, Williams & Wilkins, Baltimore, 1989
24. Manfio, G. P.; J. Zakrzewska-Czerwinska, E. Atalan & M. Goodfellow: Towards minimal standards for the description of Streptomyces species. Biotechnologia 7-8: 242-253, 1995
25. Manfio, G. P.; E. Atalan, J. Zakrzewska-Czerwinska, M. Mordarski, C. Rodriguez, M. D. Collins & M. Goodfellow: Classification of novel soil streptomycetes as Streptomyces aureus sp. nov., Streptomyces laceyi sp. nov. and Streptomyces sanglieri sp. nov. Antonie van Leeuwenhoek 82: 245-255, 2003
26. Ojika, M.; Y. Shizuri, H. Niwa, K. Yamada & S. Iwadare: Structure and synthesis of reductiline, a novel metabolite from a variant of Streptomyces orientalis. Tetrah. Lett. 23: 4977-4980, 1982
27. Gitterman, C. O.; E. L. Rickers, D. E. Wolf, J. Madas, S. B. Zimmerman, T. H. Stoudt & T. C. Demny: The human tumor-egg host system: IV. Discovery of a new anti-tumor agent, compound 593 A. J. Antibiotics 23: 305-310, 1970
28. Rithner, D. R.; R. H. Bunge, R. J. Bloem & J. C. French: PD 125375, a novel metabolite coproduced with tomaymycin. J. Org. Chem. 52: 298-300, 1987
29. Thomas, M. G.; M. D. Burkart & C. T. Walsh: Conversion of L-proline to pyrrolyl-2-carboxyl-S-PCP during undecylprodigiosin and pyoluteorin biosynthesis. Chem. Biol. 9: 171-184, 2002